These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2843325)

  • 1. Failure of polymyxin B nonapeptide to augment bactericidal activities of novobiocin, rifampin, and of defibrinated human blood against Serratia marcescens.
    Traub WH; Kohl KH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(3):195-201. PubMed ID: 2843325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B.
    Traub WH
    Chemotherapy; 1982; 28(5):363-8. PubMed ID: 6291867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.
    Traub WH; Kleber I
    Chemotherapy; 1975; 21(3-4):189-204. PubMed ID: 169108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro additive effect of polymxin B and rifampin against Serratia marcesen.
    Traub WH; Kleber I
    Antimicrob Agents Chemother; 1975 Jun; 7(6):874-6. PubMed ID: 168807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.
    Traub WH
    Chemotherapy; 1983; 29(1):48-57. PubMed ID: 6339180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. I. Cotrimoxazole, nalidixic acid, nitrofurantoin, and trimethoprim.
    Traub WH
    Chemotherapy; 1982; 28(5):369-80. PubMed ID: 6754280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections.
    Ostenson RC; Fields BT; Nolan CM
    Antimicrob Agents Chemother; 1977 Dec; 12(6):655-9. PubMed ID: 201214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
    von Graevenitz A; Zollinger-Iten J
    Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. II. Aminoglycosides: amikacin, gentamicin, and netilmicin.
    Traub WH
    Chemotherapy; 1982; 28(6):434-43. PubMed ID: 6761079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Traub WH
    Chemotherapy; 1984; 30(6):379-86. PubMed ID: 6097410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-disorganizing property of polymyxin B nonapeptide.
    Lam C; Hildebrandt J; Schütze E; Wenzel AF
    J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide.
    Viljanen P; Vaara M
    Antimicrob Agents Chemother; 1984 Jun; 25(6):701-5. PubMed ID: 6331296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and electrophoretic changes induced by polymyxin B on outer membrane components from Serratia marcescens.
    Brown DA; Tsang JC
    J Antibiot (Tokyo); 1978 Jun; 31(6):603-9. PubMed ID: 210151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of polymyxin B nonapeptide on Aeromonas salmonicida.
    McCashion RN; Lynch WH
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1414-9. PubMed ID: 2823698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraphagocytic bactericidal activity of ofloxacin compared with that of aztreonam and ceftriaxone against Serratia marcescens.
    Traub WH; Spohr M; Bauer D
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):85-94. PubMed ID: 3518296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of polysaccharide components in polymyxin B treated cells of Serratia marcescens.
    Weber DA; Nadakavukaren MJ; Tsang JC
    J Antibiot (Tokyo); 1978 Jul; 31(7):732-5. PubMed ID: 211111
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined serum bactericidal and phagocytic activities of defibrinated human blood against Serratia marcescens. Use of phenylbutazone to selectively block phagocytic killing activity and of Group A (phage tail) bacteriocins to kill extraphagocytic bacteria.
    Traub WH
    Chemotherapy; 1982; 28(5):355-62. PubMed ID: 6754279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of polymyxin B on kappa phage adsorption on Serratia marcescens HY.
    Patel KA; Patel IR; Mehta AM; Dave PJ
    Indian J Exp Biol; 1980 Nov; 18(11):1353-4. PubMed ID: 6260637
    [No Abstract]   [Full Text] [Related]  

  • 20. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.